Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study

• Published in: Annals of intensive care Vol. 10; no. 1; pp. 99 - 21
• Main Authors: Liu, Jiao, Zhang, Sheng, Wu, Zhixiong, Shang, You, Dong, Xuan, Li, Guang, Zhang, Lidi, Chen, Yizhu, Ye, Xiaofei, Du, Hangxiang, Liu, Yongan, Wang, Tao, Huang, SiSi, Chen, Limin, Wen, Zhenliang, Qu, Jieming, Chen, Dechang
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 31.07.2020; Springer Nature B.V; SpringerOpen
• Subjects: Anesthesiology; Antiviral drugs; Clinical outcomes; Cohort analysis; Coronaviruses; COVID-19; Critical Care Medicine; Development; Diabetes; Emergency Medicine; Intensive; Intensive care; Laboratories; Medicine; Medicine & Public Health; Mortality; Risk factors; Severe; Severe acute respiratory syndrome coronavirus 2; Thrombocytopenia; Wuhan China; China; COVID-19; Development; Severe; Mortality; Risk factors

Background Since December 2019, an outbreak of Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) initially emerged in Wuhan, China, and has spread worldwide now. Clinical features of patients with COVID-19 have been described. However, ris...